Using In silico LD clumping and meta-analysis of genome-wide datasets as a complementary tool to investigate and validate new candidate biomarkers in Alzheimer's disease.
Medway C, Shi H, Bullock J, Black H, Brown K, Vafadar-Isfahani B, Matharoo-Ball B, Ball G, Rees R, Kalsheker N, et al. Int J Mol Epidemiol Genet. 2010 Mar 18; 1(2):134-44. Epub 2010 Mar 18.